Methods for treating hcv infection
AssigneeInhibikase Therapeutics, Inc.
InventorMilton H Werner
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating HCV infection in subjects (e.g., mammals), comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor or a prodrug thereof. The present invention also provides methods of treating HCV infection, comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor conjointly with at least one additional therapeutic agent (e.g., an antiviral agent).
Claims16
A method of treating a viral infection, such as an HCV infection, in a subject in need thereof, comprising administering to the subject an effective amount of a RAF kinase inhibitor or a prodrug thereof.
Dependencies are inferred from the claim text.